211 related articles for article (PubMed ID: 10188965)
1. Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist.
Reavill C; Kettle A; Holland V; Riley G; Blackburn TP
Br J Pharmacol; 1999 Feb; 126(3):572-4. PubMed ID: 10188965
[TBL] [Abstract][Full Text] [Related]
2. Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.
Wadenberg MG; Browning JL; Young KA; Hicks PB
Pharmacol Biochem Behav; 2001 Mar; 68(3):363-70. PubMed ID: 11325387
[TBL] [Abstract][Full Text] [Related]
3. Effects of 5-HT(2A) and 5-HT(2C) receptor antagonists on acute and chronic dyskinetic effects induced by haloperidol in rats.
Creed-Carson M; Oraha A; Nobrega JN
Behav Brain Res; 2011 Jun; 219(2):273-9. PubMed ID: 21262266
[TBL] [Abstract][Full Text] [Related]
4. m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT(2C) receptors but not 5-HT(2A) or 5-HT(2B) receptors.
Gleason SD; Lucaites VL; Shannon HE; Nelson DL; Leander JD
Behav Pharmacol; 2001 Dec; 12(8):613-20. PubMed ID: 11856898
[TBL] [Abstract][Full Text] [Related]
5. Serotonergic involvement in haloperidol-induced catalepsy.
Neal-Beliveau BS; Joyce JN; Lucki I
J Pharmacol Exp Ther; 1993 Apr; 265(1):207-17. PubMed ID: 8386235
[TBL] [Abstract][Full Text] [Related]
6. Effects of 5-HT in globus pallidus on haloperidol-induced catalepsy in rats.
Wei L; Chen L
Neurosci Lett; 2009 Apr; 454(1):49-52. PubMed ID: 19429052
[TBL] [Abstract][Full Text] [Related]
7. Anticataleptic properties of alpha2 adrenergic antagonists in the crossed leg position and bar tests: differential mediation by 5-HT1A receptor activation.
Kleven MS; Assié MB; Cosi C; Barret-Grévoz C; Newman-Tancredi A
Psychopharmacology (Berl); 2005 Feb; 177(4):373-80. PubMed ID: 15448976
[TBL] [Abstract][Full Text] [Related]
8. 5-HT2 receptor blockade by ICI 170,809 does not affect the inhibitory effect of the 5-HT1A receptor ligand gepirone on neuroleptic-induced catalepsy.
Pires JG; Silva SR; Futuro-Neto HA
Braz J Med Biol Res; 1994 Oct; 27(10):2437-41. PubMed ID: 7640635
[TBL] [Abstract][Full Text] [Related]
9. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats.
Varty GB; Bakshi VP; Geyer MA
Neuropsychopharmacology; 1999 Apr; 20(4):311-21. PubMed ID: 10088132
[TBL] [Abstract][Full Text] [Related]
10. Involvement of presynaptic 5-HT
Mombereau C; Arnt J; Mørk A
Pharmacol Biochem Behav; 2017 Feb; 153():141-146. PubMed ID: 28057524
[TBL] [Abstract][Full Text] [Related]
11. Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats.
Fijał K; Popik P; Nikiforuk A
Psychopharmacology (Berl); 2014 Jan; 231(1):269-81. PubMed ID: 23954911
[TBL] [Abstract][Full Text] [Related]
12. The cataleptogenic effects of the neuroleptic nemonapride are attenuated by its 5-HT1A receptor agonist properties.
Prinssen EP; Kleven MS; Koek W
Eur J Pharmacol; 1998 Sep; 356(2-3):189-92. PubMed ID: 9774248
[TBL] [Abstract][Full Text] [Related]
13. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
Metwally KA; Dukat M; Egan CT; Smith C; DuPre A; Gauthier CB; Herrick-Davis K; Teitler M; Glennon RA
J Med Chem; 1998 Dec; 41(25):5084-93. PubMed ID: 9836624
[TBL] [Abstract][Full Text] [Related]
14. Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.
Ninan I; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):603-8. PubMed ID: 10669905
[TBL] [Abstract][Full Text] [Related]
15. Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum.
Lucas G; Spampinato U
J Neurochem; 2000 Feb; 74(2):693-701. PubMed ID: 10646521
[TBL] [Abstract][Full Text] [Related]
16. Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats.
Ball KT; Rebec GV
Psychopharmacology (Berl); 2005 Oct; 181(4):676-87. PubMed ID: 16001122
[TBL] [Abstract][Full Text] [Related]
17. Effects of the 5-HT2C/2B antagonist SB 206553 on hyperactivity induced by cocaine.
McCreary AC; Cunningham KA
Neuropsychopharmacology; 1999 Jun; 20(6):556-64. PubMed ID: 10327425
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo characterization of the dopamine D4 receptor, serotonin 5-HT2A receptor and alpha-1 adrenoceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl]thiazole (NRA0045).
Okuyama S; Chaki S; Yoshikawa R; Suzuki Y; Ogawa S; Imagawa Y; Kawashima N; Ikeda Y; Kumagai T; Nakazato A; Nagamine M; Tomisawa K
J Pharmacol Exp Ther; 1997 Jul; 282(1):56-63. PubMed ID: 9223539
[TBL] [Abstract][Full Text] [Related]
19. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
[TBL] [Abstract][Full Text] [Related]
20. Conformationally constrained butyrophenones with affinity for dopamine (D(1), D(2), D(4)) and serotonin (5-HT(2A), 5-HT(2B), 5-HT(2C)) receptors: synthesis of aminomethylbenzo[b]furanones and their evaluation as antipsychotics.
Raviña E; Casariego I; Masaguer CF; Fontenla JA; Montenegro GY; Rivas ME; Loza MI; Enguix MJ; Villazon M; Cadavid MI; Demontis GC
J Med Chem; 2000 Nov; 43(24):4678-93. PubMed ID: 11101359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]